ADVFN US – Market Content Editor

American Fusion (USOTC:AMFN) has upgraded key equipment for its Texatron Fusion Engine testing programme while pursuing potential commercial deployments, scientific review and financing discussions. The developments indicate progress across several workstreams, although technical validation and binding customer agreements remain outstanding. Key Investor Takeaways Why AMFN Stock Is in Focus American Fusion has provided an operational…

NioCorp Developments (NASDAQ:NB) has signed a binding 15-year agreement with Traxys North America, extending commercial arrangements across its planned Elk Creek critical minerals production and potentially strengthening its position in financing discussions with the U.S. Export-Import Bank. Key Investor Takeaways Why NB Stock Is in Focus NioCorp Developments has reached a definitive commercial agreement with…

CANEX Metals (USOTC:NOMNF) has secured a British Columbia Supreme Court ruling declaring the Helix Resources joint venture agreement unenforceable, removing a legal dispute over rights to its Gold Basin gold project in Arizona as the company advances exploration and drilling preparations. Key Investor Takeaways Why NOMNF Stock Is in Focus CANEX Metals has confirmed that…

Roche (USOTC:RHHBY) has secured exclusive worldwide rights to Rona Therapeutics’ investigational ALK7-targeting RNA interference therapy for obesity and metabolic diseases, expanding its pipeline with a treatment approach focused on fat tissue rather than appetite regulation. Key Investor Takeaways Why RHHBY Stock Is in Focus Rona Therapeutics has granted Roche an exclusive worldwide licence to develop…

Rail Vision (NASDAQ:RVSN) will present its latest AI-powered railway safety solutions and commercial developments at the 20th Annual LD Micro Main Event on October 21, 2026, providing investors with an opportunity to assess its expanding product portfolio and North American market activities. Key Investor Takeaways Why RVSN Stock Is in Focus Rail Vision has confirmed…

Scinai Immunotherapeutics (NASDAQ:SCNI) has secured a $5.1 million development and clinical manufacturing agreement with a US-listed biotechnology company, increasing its committed customer orders to approximately $7.6 million and improving revenue visibility through 2027. Key Investor Takeaways Why SCNI Stock Is in Focus Scinai Immunotherapeutics has expanded its contract development and manufacturing organisation (CDMO) business through…

Bumble Inc. (NASDAQ:BMBL) has agreed to be acquired by Ithaca Holdings in a $1.3 billion transaction, offering shareholders a substantial premium and setting the dating platform on a path toward private ownership. Key Investor Takeaways Why BMBL Stock Is in Focus Bumble has entered into a definitive agreement to be acquired by Ithaca Holdings, marking…

Pinnacle Food Group (NASDAQ:PFAI) has confirmed recombinant human lactoferrin production using methanol-free fermentation technology, marking an early technical milestone in its precision fermentation programme and supporting further development toward potential commercial scale-up. Key Investor Takeaways Why PFAI Stock Is in Focus Pinnacle Food Group has completed its first controlled bench-scale fermentation of recombinant human lactoferrin…